Nowadays, Semler Scientific announced It has raised its Bitcoin companies. The company acquired 185 Bitcoin between 23 May and 3 June for $ 20 million with an average purchase price of $ 107,974 per Bitcoin, using the revenues from the AT-the-Market (ATM) offering program.
“We continue to grow our Bitcoin arsenal accretief with the help of operational cash flow and yield of debt and stock financing,” said the chairman of Semler Scientific Eric Semler. “And we are delighted to launch the Semler Scientific Dashboard on our website today to regularly provide the public information about our Bitcoin Holdings and other important statistics.”
Since the launch of the ATM program in April 2025, Semler has raised around $ 136.2 million under the sales agreement of more than 3.6 million shares of its ordinary shares.
From 3 June 2025, Semler owns 4,449 bitcoin that were taken over for an amount of $ 410.0 million, with an average purchase price of $ 92.158 per bitcoin. At the time of writing, the market value of these companies is around $ 446.2 million.
Eric Semler placed on X: “SMLR acquires 185 bitcoins for $ 20 million and has generated BTC revenue of 26.7% YTD. Now 4,449 $ BTC.”
Semler Scientific uses the BTC yield as an important performance -indicator (KPI) to assess the performance of the strategy of acquiring Bitcoin. From year to date, the company has achieved a BTC yield of 26.7%.
“Semler Scientific is of the opinion that this KPI can be used to supplement the understanding of an investor of Semler Scientific to finance the purchase of Bitcoin by converting extra shares of its ordinary shares or instruments into ordinary shares,” said the 8-K-shape.
Semler Scientific reported a difficult quarter in Q1 FY2025. The turnover amounted to $ 8.8 million, a decrease of 44% on an annual basis. Operating costs rose last year to $ 39.9 million from $ 8.9 million, mainly due to a contingent liability of $ 29.8 million linked to the potential settlement with the Doj. This led to an operational loss of $ 31.1 million, compared to a profit of $ 7.0 million in Q1 2024.
“Our health care is seeing green shoots of the cardiovascular product line that we have introduced this year in our large customer base,” said the CEO of Semler Scientific Doug Murphy-Chutorian. “We expect growth and generating cash of these products and services related by the FDA, which will contribute to our Bitcoin Treasury strategy.”